Literature DB >> 16564703

Increased production of IL-1alpha and TNF-alpha in lipopolysaccharide-stimulated blood from obese patients with non-alcoholic fatty liver disease.

Jaime Poniachik1, Attila Csendes, Juan C Díaz, Jorge Rojas, Patricio Burdiles, Fernando Maluenda, Gladys Smok, Ramón Rodrigo, Luis A Videla.   

Abstract

Enhanced pro-inflammatory cytokine production is considered a pathogenic factor in non-alcoholic fatty liver disease (NAFLD). Peripheral blood production of interleukin-1alpha (IL-1alpha) and tumor necrosis factor-alpha (TNF-alpha) was studied in relation to the severity of histological changes of the liver in obese NAFLD patients. Basal levels in serum and production of IL-1alpha and TNF-alpha in peripheral blood cell cultures after stimulation with lipopolysaccharide (enzyme-linked immunoabsorbent assays) were measured in 11 patients with steatosis and 15 with steatohepatitis, who underwent gastrectomy with a gastro-jejunal anastomosis in roux and Y, and in 9 controls who underwent anti-reflux surgery. Production of IL-1alpha and TNF-alpha was 122 and 67% higher in patients with steatosis than control values, respectively. In patients with steatohepatitis, IL-1alpha production was 300 and 80% higher and that of TNF-alpha 110 and 26% higher, as compared with controls and steatosis patients, respectively. Production of IL-1alpha was positively correlated with that of TNF-alpha (r=0.78, p<0.0001). IL-1alpha and TNF-alpha production were both positively correlated with the degree of steatosis (r=0.68, p<0.001 and r=0.74, p<0.0001) and steatohepatitis (r=0.77 and r=0.75, p<0.0001) at liver biopsy, and with the homeostasis model assessment index (r=0.73, p<0.0001 and r=0.63, p<0.01), respectively. Basal serum IL-1alpha and TNF-alpha levels were comparable in the three groups studied. It is concluded that elevated production of IL-1alpha and TNF-alpha by in vitro stimulated whole blood cell cultures occurs in NAFLD obese patients, which might play a pathophysiological role upon inflammatory leukocyte infiltration of the liver.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16564703     DOI: 10.1016/j.cyto.2006.02.006

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  22 in total

1.  Increased interleukin 1 and tumor necrosis factor alpha levels after thyroid surgery.

Authors:  Beyza Özçınar; Nihat Aksakal; Fatih Yanar; Orhan Ağcaoğlu; Kıvanç Derya Peker; Ümit Türkoğlu; Selçuk Mercan; Selçuk Özarmağan; Yeşim Erbil
Journal:  Ulus Cerrahi Derg       Date:  2014-06-01

2.  Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis: association with toll-like receptor 4 expression and plasma levels of interleukin 8.

Authors:  Ahmed Abu Shanab; Paul Scully; Orla Crosbie; Martin Buckley; Liam O'Mahony; Fergus Shanahan; Sanaa Gazareen; Eileen Murphy; Eamonn M M Quigley
Journal:  Dig Dis Sci       Date:  2010-11-03       Impact factor: 3.199

3.  N-acetylcysteine attenuates progression of liver pathology in a rat model of nonalcoholic steatohepatitis.

Authors:  January N Baumgardner; Kartik Shankar; Leah Hennings; Emanuele Albano; Thomas M Badger; Martin J J Ronis
Journal:  J Nutr       Date:  2008-10       Impact factor: 4.798

4.  Lack of interleukin-1α or interleukin-1β inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice.

Authors:  Yehuda Kamari; Aviv Shaish; Einav Vax; Shay Shemesh; Michal Kandel-Kfir; Yaron Arbel; Sarita Olteanu; Iris Barshack; Shahar Dotan; Elana Voronov; Charles A Dinarello; Ron N Apte; Dror Harats
Journal:  J Hepatol       Date:  2011-02-24       Impact factor: 25.083

Review 5.  The immunopathogenesis of alcoholic and nonalcoholic steatohepatitis: two triggers for one disease?

Authors:  Luca Valenti; Anna Ludovica Fracanzani; Silvia Fargion
Journal:  Semin Immunopathol       Date:  2009-05-14       Impact factor: 9.623

6.  Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-α production.

Authors:  Annie-Carole Tosello-Trampont; Susan G Landes; Virginia Nguyen; Tatiana I Novobrantseva; Young S Hahn
Journal:  J Biol Chem       Date:  2012-10-12       Impact factor: 5.157

7.  Gene expression patterns in hepatic tissue and visceral adipose tissue of patients with non-alcoholic fatty liver disease.

Authors:  Ancha Baranova; Karen Schlauch; Hazem Elariny; Mohammed Jarrar; Chase Bennett; Clare Nugent; Shobha J Gowder; Zahra Younoszai; Rochelle Collantes; Vikas Chandhoke; Zobair M Younossi
Journal:  Obes Surg       Date:  2007-08       Impact factor: 4.129

8.  sTRAIL levels and TRAIL gene polymorphisms in Chinese patients with fatty liver disease.

Authors:  Xiaohua Yan; Liyun Xu; Jianni Qi; Xiaohong Liang; Chunhong Ma; Chun Guo; Lining Zhang; Wensheng Sun; Jiyun Zhang; Xiaoyi Wei; Lifen Gao
Journal:  Immunogenetics       Date:  2009-07-23       Impact factor: 2.846

9.  Change of intestinal mucosa barrier function in the progress of non-alcoholic steatohepatitis in rats.

Authors:  Sheng Li; Wan-Chun Wu; Chi-Yi He; Zhen Han; Dao-You Jin; Lin Wang
Journal:  World J Gastroenterol       Date:  2008-05-28       Impact factor: 5.742

Review 10.  Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease.

Authors:  Kamran Qureshi; Gary A Abrams
Journal:  World J Gastroenterol       Date:  2007-07-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.